Skip to content

Evaluating the effect of thiamine on delirium

Evaluating the preventive effect of vitamin B1 on Delirium in critically ill patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190224042815N1
Enrollment
90
Registered
2019-07-24
Start date
2640-05-18
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post operation. Delirium due to known physiological condition

Interventions

Intervention 1: "Intervention Group" : 'The group receiving thiamine hydrochloride 50 mg/ml ampule Ratiopharm GmbH company is injected at a daily dose of 200 mg (4 ampulla ) in serum for three days.

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with age more than 18 years-old Patients undergoing gastrointestinal surgery Patients admitted to the intensive care unit after gastrointestinal surgery Patients who have proper alertness to enter to the study Patient satisfaction at the time of entering the study

Exclusion criteria

Exclusion criteria: Patients with age less than 18 year-old Patients with chronic alcohol consumption Pregnancy Patients with severe electrolyte and metabolic disorders Patients with severe liver failure Patients with central nervous system problems

Design outcomes

Primary

MeasureTime frame
Prevention of Delirium after Gastrointestinal Surgery. Timepoint: Days 2-4. Method of measurement: Evaluation of delirium incidence based on Confusion Assessment method for the Intensive Care Unite (CAM_ICU).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNiayesh Mohebbi

Tehran University of Medical Sciences

Niayeshmohebbi@yahoo.com+98 21 6658 1598

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026